Last updated: 16 June 2019 at 8:51am EST

David Earp Net Worth




The estimated Net Worth of David Earp is at least $2.21 millió dollars as of 1 June 2012. David Earp owns over 27,155 units of Geron stock worth over $2,051,912 and over the last 21 years David sold GERN stock worth over $158,622.

David Earp GERN stock SEC Form 4 insiders trading

David has made over 3 trades of the Geron stock since 2011, according to the Form 4 filled with the SEC. Most recently David sold 27,155 units of GERN stock worth $37,202 on 1 June 2012.

The largest trade David's ever made was selling 27,155 units of Geron stock on 1 June 2012 worth over $37,202. On average, David trades about 2,638 units every 18 days since 2003. As of 1 June 2012 David still owns at least 467,406 units of Geron stock.

You can see the complete history of David Earp stock trades at the bottom of the page.



What's David Earp's mailing address?

David's mailing address filed with the SEC is , , , , .

Insiders trading at Geron

Over the last 21 years, insiders at Geron have traded over $2,393,273 worth of Geron stock and bought 340,678 units worth $567,384 . The most active insiders traders include John A Scarlett, Daniel Bradbury és Stephen Rosenfield. On average, Geron executives and independent directors trade stock every 93 days with the average trade being worth of $587,812. The most recent stock trade was executed by Andrew J Grethlein on 8 July 2024, trading 674,348 units of GERN stock currently worth $1,159,879.



What does Geron do?

we are a biopharmaceutical company developing first-in-class therapies for cancer. imetelstat, a novel, first-in-class telomerase inhibitor, is our product candidate in clinical development. telomerase enables cancer cells to maintain telomere length, which provides them with the capacity for limitless cellular replication. imetelstat is a potent and specific inhibitor of telomerase. based on clinical data we obtained in late 2012, we may develop imetelstat to treat one or more hematologic myeloid malignancies such as myelofibrosis, or mf, myelodysplastic syndromes, or acute myelogenous leukemia.



What does Geron's logo look like?

Geron Corp. logo

Complete history of David Earp stock trades at Geron

Dátum
#
Cég
Az érdekelt
Trans.
Tranzakció
Részvények száma Ár per részvény Teljes ár Részvények szíma után Forrás
1 Jun 2012 David Earp
VP Intellectual Property
Eladás 27,155 $1.37 $37,202
1 Jun 2012
467,406
14 Jun 2011 David Earp
VP Intellectual Property
Eladás 25,262 $4.28 $108,121
14 Jun 2011
494,561
20 May 2011 David Earp
VP Intellectual Property
Eladás 2,975 $4.47 $13,298
20 May 2011
519,823


Geron executives and stock owners

Geron executives and other stock owners filed with the SEC include: